ArriVent BioPharma (AVBP) PT Raised to $45 at Citi
Tweet
Share
E-mailGet Alerts AVBP Hot Sheet
Price: $30.51 --0%
Rating Summary:
13 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 7 | New: 15
Rating Summary:
13 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 7 | New: 15
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on ArriVent BioPharma (NASDAQ: AVBP) to $45.00 (from $33.00) while maintaining a Buy rating.
You May Also Be Interested In
- Deutsche Bank Upgrades Azimut Holdings SpA (AZM:IM) (AZIHY) to Buy
- Banco BPM SpA (BAMI:IM) (BNCZF) PT Raised to EUR18.10 at Deutsche Bank
- Aedifica SA (AED:BB) PT Lowered to EUR82 at Kepler Cheuvreux
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
